Home / Market News / $FFLY

$FFLY news and market catalysts

The 9 most recent market catalysts affecting $FFLY, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

9 catalysts 0 high impact 8 bullish 1 bearish Aerospace & Defense
Nov 17, 2026 Corporate Catalyst Bullish Impact 55
Firefly Aerospace Adds QASCOM as Commercial Customer on Elytra for Lunar Orbit Operations
Firefly Aerospace announced a new commercial agreement with QASCOM to deploy the COLLINS system on its Elytra vehicle during the Blue Ghost mission to the Moon in 2028. This agreem…
Nov 17, 2026 Corporate Catalyst Bullish Impact 65
Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans
Firefly Neuroscience reported a 373% year-over-year increase in its U18 ADHD Evoke™ scan volume, a key metric for its diagnostic service. This growth is attributed to successful co…
Nov 11, 2026 Corporate Catalyst Bullish Impact 75
Firefly Neuroscience Reports Third Quarter 2026 Financial Results
Firefly Neuroscience announced its third-quarter 2026 financial results, showcasing a 67% year-over-year revenue increase to $647,000, primarily due to recurring subscription reven…
Oct 27, 2026 Corporate Catalyst Bullish Impact 65
Firefly Neuroscience Strengthens Non-Invasive Brain-Computer Interface Growth Strategy
Firefly Neuroscience announced a strategic update detailing its advancements in the non-invasive brain-computer interface (BCI) market. The company is utilizing an AI foundation mo…
Sep 25, 2026 Corporate Catalyst Bullish Impact 75
Firefly Neuroscience shares are trading higher after the company announced a partnership with NeuroSigma to expand access to the Monarch eTNS System through its Evoke clinician network.
This partnership is a significant corporate catalyst for Firefly Neuroscience, as it directly addresses market access and distribution for a key product, the Monarch eTNS System. T…
Sep 25, 2026 Corporate Catalyst Bullish Impact 65
Firefly Neuroscience Partners With NeuroSigma To Expand Clinician Awareness Of And Access To The Monarch eTNS System
Firefly Neuroscience is entering a strategic partnership with NeuroSigma to expand the reach of NeuroSigma's Monarch eTNS System, an FDA-cleared non-drug treatment for pediatric AD…
Sep 17, 2026 Corporate Catalyst Bullish Impact 75
Firefly Neuroscience shares are trading higher after the company announced a strategic collaboration with Radial to pursue integration of AI-powered Evoke EEG/ERP platform with RadialOS.
This announcement is a significant positive catalyst for Firefly Neuroscience (FFLY) as it signals a strategic move to enhance its core product through AI integration and broader m…
Sep 14, 2026 Corporate Catalyst Bearish Impact 75
Firefly Neuroscience Announces Termination Of CFO Paul Krzywicki Effective September 24
Firefly Neuroscience filed an 8-K to disclose the termination of its Chief Financial Officer, Paul Krzywicki, effective September 24. The departure of a CFO, especially without imm…
Aug 5, 2026 Corporate Catalyst Bullish Impact 75
Firefly Neuroscience Says TMS Center Customer Clinical Assessments Using Evoke Platform Rose 291% Year-Over-Year
The 291% year-over-year increase in clinical assessments using Firefly Neuroscience's Evoke Platform is a strong indicator of growing demand and successful market penetration for t…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.